Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study Evaluating the Impact of Regular FODMAP-targeting Digestive Enzyme Blend Use on Gastrointestinal Symptoms in Individuals With Self-Reported Bloating

NCT07591584 is registered in ClinicalTrials.gov with Kiwi Health Inc as lead sponsor.

NCT NCT07591584
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07591584 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study Evaluating the Impact of Regular FODMAP-targeting Digestive Enzyme Blend Use on Gastrointestinal Symptoms in Individuals With Self-Reported Bloating
Lead sponsor
Kiwi Health Inc
Phase
Not applicable
Overall status
Recruiting
Start date
May 4, 2026
Completion date
October 26, 2026
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal pain, bloating, gut health, ibs (irritable bowel syndrome)